Provided by Tiger Trade Technology Pte. Ltd.

Fulgent Genetics Inc.

19.45
-0.4523-2.27%
Volume:52.97K
Turnover:1.03M
Market Cap:535.11M
PE:-6.92
High:19.89
Open:19.89
Low:19.27
Close:19.90
52wk High:31.04
52wk Low:13.46
Shares:27.52M
Float Shares:16.48M
Volume Ratio:0.43
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8094
EPS(LYR):-1.9700
ROE:-8.11%
ROA:-6.30%
PB:0.53
PE(LYR):-9.87

Loading ...

Fulgent Genetics Q1 Adj. EPS $(0.36) Misses $(0.10) Estimate, Sales $71.138M Beat $68.095M Estimate

Benzinga Earnings
·
May 01

BRIEF-Fulgent Genetics Q1 Revenue USD 71.138 Million

Reuters
·
May 01

Fulgent Genetics Q1 Pretax Profit USD -25.978 Million

THOMSON REUTERS
·
May 01

Fulgent Genetics Inc: Reiterates Revenue Guidance for Fiscal Year 2026

THOMSON REUTERS
·
May 01

Fulgent Genetics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Apr 29

Fulgent presents Phase 2 FID-007 plus cetuximab data at ASCO annual meeting

Reuters
·
Apr 23

Press Release: Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026

Dow Jones
·
Apr 16

Fulgent Genetics to release first-quarter results, host conference call

Reuters
·
Apr 16

Fulgent Genetics announces annual shareholder meeting

Reuters
·
Apr 01

Fulgent Genetics completes acquisition of Bako Diagnostics and StrataDx for USD 56.9 million

Reuters
·
Mar 18

Fulgent Genetics Completes Acquisition of Bako Diagnostics and Stratadx

THOMSON REUTERS
·
Mar 18

Portnoy Law Firm probes Fulgent Genetics for possible securities fraud after 38% stock plunge

Reuters
·
Mar 13

UBS Adjusts Fulgent Genetics Price Target to $22 From $35, Maintains Buy Rating

MT Newswires Live
·
Mar 02

Fulgent Genetics price target lowered to $22 from $35 at UBS

TIPRANKS
·
Mar 02

Top Midday Decliners

MT Newswires Live
·
Feb 28

Fulgent Genetics Shares Plunge on Wider 4Q Loss, FY Outlook Miss

Dow Jones
·
Feb 27

Fulgent Genetics Shares Fall 11% Premarket After Co Forecasts FY26 Revenue Below Estimates

THOMSON REUTERS
·
Feb 27

GUIDANCE: (FLGT) Fulgent Genetics Expects 2026 Revenue About $350M, vs. FactSet Est of $356.3M

MT Newswires Live
·
Feb 27

GUIDANCE: (FLGT) Fulgent Expects 2026 Adjusted Loss About $1.45 a Share, vs. FactSet Est of $0.32 Loss

MT Newswires Live
·
Feb 27

Earnings Flash (FLGT) Fulgent Genetics Posts Q4 Revenue $83.3M, vs. FactSet Est of $85.4M

MT Newswires Live
·
Feb 27